Pathology Analysis & Statistics, January 2015

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

1-50 of about 408 000 reports

Purchase Reports From Reputable Market Research Publishers

2014-2018 World Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Japan, Spain, UK, US

2014-2018 World Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21 100
  • Industry report
  • November 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

  • Industries : Pathology
  • Countries : Italy, Germany, Japan, Spain, World, United States, Europe, United Kingdom, France
2014-2018 European Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, UK

2014-2018 European Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers--France, Germany, Italy, Spain, UK

  • $ 12 800
  • Industry report
  • November 2014
  • by Venture Planning Group

“Emerging Opportunities in the European Virology and Bacteriology Testing Market” is a new five-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

  • Industries : Pathology
  • Countries : Spain, Italy, Germany, Europe
Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8 119
  • Industry report
  • December 2014
  • by Firstword Pharma

The Ulcerative Colitis (UC) treatment market is already undergoing radical change as new, safer products that slow disease progression have come to market or will be launched in the next few years. While ...

  • Industries : Pathology
  • Countries : United States
Global Mobile Healthcare Market Devices, Applications, Services Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast 2014-20

Global Mobile Healthcare Market Devices, Applications, Services Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast 2014-20

  • $ 7 000
  • Industry report
  • November 2014
  • by Occams

According to WHO approximately 17.3 million people die annually due to CVD and the condition is responsible for 30 percent of the global deaths. Also, 80 percent of CVD deaths take place in low and middle ...

  • Industries : Pathology
Global Mobile Healthcare Market Devices, Applications, Services (Remote Monitoring, Heart Rate Monitors, SMBG, Blood Pressure, Neurological, GMH,CBT, Smartphone Mobile Healthcare) Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast

Global Mobile Healthcare Market Devices, Applications, Services (Remote Monitoring, Heart Rate Monitors, SMBG, Blood Pressure, Neurological, GMH,CBT, Smartphone Mobile Healthcare) Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast

  • $ 7 000
  • Industry report
  • November 2014
  • by Occams

According to WHO approximately 17.3 million people die annually due to CVD and the condition is responsible for 30 percent of the global deaths. Also, 80 percent of CVD deaths take place in low and middle ...

  • Industries : Pathology
Global Mobile Healthcare Market Devices, Applications, Services (Remote Monitoring, Heart Rate Monitors, SMBG, Blood Pressure, Neurological, GMH,CBT, Smartphone Mobile Healthcare) Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast

Global Mobile Healthcare Market Devices, Applications, Services (Remote Monitoring, Heart Rate Monitors, SMBG, Blood Pressure, Neurological, GMH,CBT, Smartphone Mobile Healthcare) Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast

  • $ 7 000
  • Industry report
  • November 2014
  • by Occams

The mobile healthcare market is growing due to technological advancement in the mobile healthcare products, rise in lifestyle oriented diseases and awareness. The mobile healthcare market involves all ...

  • Industries : Pathology
Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The prostate cancer pipeline is among the largest in the ...

  • Industries : Pathology
Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in Parkinson's Disease Pipeline The Parkinson's disease (PD) pipeline ...

  • Industries : Pathology
PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - 5EU Drug ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, United Kingdom, Europe, World
Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • October 2014
  • by GBI Research

Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development ...

  • Industries : Pathology
Biological Therapies for Cancer: Technologies and Global Markets

Biological Therapies for Cancer: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of ...

  • Industries : Pathology
  • Countries : World
Breast Cancer Diagnostic and Drug Technologies: Global Markets

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion ...

  • Industries : Pathology
  • Countries : World
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

  • $ 4 995
  • Industry report
  • November 2014
  • by GBI Research

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - US Drug ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - Japan ...

  • Industries : Pathology
  • Countries : Japan
PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - China ...

  • Industries : Pathology
  • Countries : China
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries

Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries

  • $ 4 995
  • Industry report
  • October 2014
  • by GBI Research

Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries Summary GBI Research, the leading business ...

  • Industries : Pathology
  • Countries : World
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

  • $ 4 995
  • Industry report
  • October 2014
  • by GBI Research

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options Summary GBI Research, a leading business ...

  • Industries : Pathology
  • Countries : World
Infectious Disease Diagnostics Market by Product, Application, Technology, End User (Hospital, Laboratories) - Global Forecast to 2019

Infectious Disease Diagnostics Market by Product, Application, Technology, End User (Hospital, Laboratories) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • January 2015
  • by MarketsandMarkets

Increasing Prevalence of Deadly Infectious Disease and Need For Highly Specific and Sensitive Technologies for Rapid Diagnosis to Drive Growth of the IDD Market The global IDD market report is segmented ...

  • Industries : Pathology
  • Countries : World, North America
Breath Analyzers Market by Technology (Fuel Cell, Semiconductor, Infrared, Crystal), by Application (Alcohol, Drug Abuse, Tuberculosis, Asthma, Cancer), by End User (Law Enforcement, Enterprises, Individuals) - Analysis & Global Forecast to 2019

Breath Analyzers Market by Technology (Fuel Cell, Semiconductor, Infrared, Crystal), by Application (Alcohol, Drug Abuse, Tuberculosis, Asthma, Cancer), by End User (Law Enforcement, Enterprises, Individuals) - Analysis & Global Forecast to 2019

  • $ 4 650
  • Industry report
  • December 2014
  • by MarketsandMarkets

Breath analyzers are devices used to detect the presence of different compounds in the breath sample of individuals. They are most commonly used to measure blood alcohol content levels (BAC). These devices ...

  • Industries : Pathology
2014-2018 French Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers

2014-2018 French Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers

  • $ 4 300
  • Industry report
  • November 2014
  • by Venture Planning Group

“Emerging Opportunities in the French Virology and Bacteriology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during ...

  • Industries : Pathology
  • Countries : France
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023 Summary Colorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks ...

  • Industries : Pathology
  • Countries : Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe
EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023 Summary Cushing's syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, ...

  • Industries : Pathology
  • Countries : World, United States
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • November 2014
  • by Global Data

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023 Summary Celiac disease is an autoimmune disease that occurs in individuals who consume gluten-containing foods but are intolerant to gluten, ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • November 2014
  • by Global Data

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune ...

  • Industries : Pathology
  • Countries : Canada, Japan, World, United States, Spain, Italy, France, Germany
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • October 2014
  • by Global Data

EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023 Summary Irritable Bowel Syndrome (IBS) is a chronic, relapsing gastrointestinal disorder that is characterized by abdominal discomfort ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Germany, United States, Italy, France
Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • December 2014
  • by Firstword Pharma

As the cancer drug market continues to face significant challenges in an environment of rising R&D costs, value-based pricing, demands for real world evidence and tougher regulation, the role of Medical ...

  • Industries : Pathology
  • Countries : Europe
Autoinjectors to 2022

Autoinjectors to 2022

  • $ 3 850
  • Industry report
  • December 2014
  • by Greystone Research Associates

Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the ...

  • Industries : Pathology
Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Avastin (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe

About 200 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Imaging Systems L.L.C.

United States

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.